Lupin informs about press release

07 Feb 2018 Evaluate

Lupin has informed about press release titled ‘Lupin and Yoshindos JV - YL Biologics announces successful outcome of global Phase III study for Etanercept biosimilar in Rheumatoid Arthritis.’

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2146.05 14.25 (0.67%)
30-Jan-2026 11:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1592.00
Dr. Reddys Lab 1222.75
Cipla 1323.50
Zydus Lifesciences 888.20
Lupin 2146.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×